Business Context and Reporting Period
Moolec Science SA filed Form 6-K for March 2024. The filing reports on the Company’s 2023 Annual Shareholders’ Meeting, held on March 11, 2024, and references annual accounts for the year ended June 30, 2023.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other quantitative financial metrics. Shareholders approved the annual accounts for the year ended June 30, 2023 and the allocation of results for that year, but the filing text does not state the underlying financial values.
Material Changes Versus the Prior Comparable Period
The filing does not present comparative financial information or identify material operating or financial changes versus a prior period.
Governance, Outlook, and Risks
- All 11 proposals submitted at the meeting were approved by a simple majority of votes expressed.
- Kyle P. Bransfield, Jose Lopez Lecube, Gastón Paladini, and Natalia Zang were reappointed as directors through the annual meeting approving the accounts for the year ending June 30, 2024.
- Esteban Corley was appointed as a director for the same term.
- The current approved statutory auditor was reappointed through the annual meeting approving the accounts for the year ending June 30, 2024.
- Shareholders approved director remuneration and granted discharge to the directors and approved statutory auditor.
- The filing provides no management guidance, business outlook, risk updates, contingencies, or unusual items.
Investor Verification Items
- Verify the approved annual accounts for the year ended June 30, 2023, including revenue, profitability, cash flow, debt, and liquidity.
- Verify the allocation of the Company’s results for fiscal 2023.
- Confirm the voting results and terms of the director and statutory auditor appointments in the complete meeting materials.
- Review subsequent filings for operating updates, financing activity, guidance, and material risks not addressed in this 6-K.